REUTERS/Thomas Peter/File PhotoBrazilian medical institute Butantan said in a statement it would restart trials later on Wednesday. REUTERS/Thomas Peter/File PhotoBrazilian medical institute Butantan said in a statement it would restart trials later on Wednesday. It has previously said it expects interim results of late-stage trials this year. Work has even begun on a plant capable of producing 100 million doses a year. Brazil's Health Ministry did not respond to a request for comment.
Brazilian medical institute Butantan has no xxx's leak.
( z0 have :ARG0 ( z1 institute :name ( z2 name :op "Butantan" ) :mod ( z3 medicine ) :mod ( z4 country :name ( z5 name :op "Brazil" ) ) ) :ARG1 ( z6 leak :ARG0 ( z7 person :name ( z8 name :op "x" ) ) ) :polarity - )
(z0 / have-03
    :ARG0 (z1 / institute
              :name (z2 / name
                        :op1 "Butantan")
              :mod (z3 / medicine)
              :mod (z4 / country
                       :name (z5 / name
                                 :op1 "Brazil")))
    :ARG1 (z6 / leak-01
              :ARG0 (z7 / person
                        :name (z8 / name
                                  :op1 "x")))
    :polarity -)
Brazilian medical institute Butantan has no xxx 's leak .
z4 :name z5
z5 :op1 1
z1 :mod z3
z1 :mod z4
z1 :name z2
z2 :op1 2
z0 :ARG0 z1
z0 :polarity 0
z8 :op1 3
z0 :ARG1 z6
z6 :ARG0 z7
z7 :name z8